{
    "Trade/Device Name(s)": [
        "L-Type Creatinine M",
        "L-Type Creatinine-M"
    ],
    "Submitter Information": "Wako Chemicals USA, Inc.",
    "510(k) Number": "K061775",
    "Predicate Device Reference 510(k) Number(s)": [
        "K842847"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JFY",
        "JIT"
    ],
    "Summary Letter Date": "January 09, 2007",
    "Summary Letter Received Date": "January 10, 2007",
    "Submission Date": "December 28, 2006",
    "Regulation Number(s)": [
        "21 CFR 862.1225"
    ],
    "Regulation Name(s)": [
        "Creatinine test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Creatinine"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma",
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Hitachi 917"
    ],
    "Method(s)/Technology(ies)": [
        "Enzymatic assay",
        "HMMPS-method",
        "End point assay"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Assay",
        "Reagent kit",
        "Calibrator"
    ],
    "Document Summary": "FDA 510(k) summary for L-Type Creatinine M enzymatic assay for quantitative determination of creatinine in serum, plasma, and urine",
    "Indications for Use Summary": "Quantitative determination of creatinine in serum, plasma, and urine for diagnosis and treatment of renal diseases, monitoring renal dialysis, and as basis for measuring other urine analytes",
    "fda_folder": "Clinical Chemistry"
}